2.57 RECOVERY, Clinical Trials in the US, EFS, Writing, Dr. Raj Chetty, & Dr. Ian Tannock

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 19 June 2020

⏱️ 135 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

This week's episode is jam-packed with topics! We talk about the RECOVERY trial, the U.S. clinical trial infrastructure, event-free survival (EFS) and cost of care in acute myeloid leukemia, how long it takes to write papers in academic medicine, threats to public health officials, and the application to medicine of Dr. Raj Chetty's work in economics. Finally, we interview this week's special guest, Dr. Ian Tannock, on docetaxel, prostrate cancer, clinical trial appraisal, and his career in medicine. RECOVERY: https://www.recoverytrial.net/ EFS in AML: doi.org/10.1182/bloodadvances.2019001150 Malignant audiobook: https://www.audible.com/pd/B08864KFHW/?source_code=AUDFPWS0223189MWT-BK-ACX0-195112&ref=acx_bty_BK_ACX0_195112_rh_us Back us on Patreon! www.patreon.com/plenarysession

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Plenary Session.
0:07.0	I'm your host, Dr. Vinay Prasad.
0:10.0	I'm a practicing hematologist, oncologist, and I'm associate professor of medicine.
0:14.0	I'm interested in issues at the intersection of medicine, oncology, and health policy,
0:19.0	and that's what you're going to get on this podcast.
0:22.4	Welcome to Season 2.
0:25.0	This week on Plenary Session, we have so much in store for you.
0:28.2	It's going to be a jam-packed episode.
0:29.7	You're not going to want to miss this.
0:31.0	First, we're going to talk about the recovery trial.
0:33.4	When can you take medicine by press release seriously, and when should you wait for the published
0:38.6	paper? We're going to get into that. We're going to talk about the U.S. clinical trial
0:42.0	infrastructure. We're going to talk about a provocative paper, EFS and cost of care in acute
0:48.8	myeloid leukemia. It's not a predictor of OS, but maybe it's a predictor of cost of care.
0:53.2	We're going to talk about why that is fantastically wrong.
0:56.6	We're going to talk about a poll I conducted on Twitter on how long it takes to write articles and what that means for the Academy.
1:02.3	We're going to talk about Raj Chetty and what he's doing with economics that we fail to do in medicine.
1:07.6	And finally, we're going to talk about threatening public health officials who are just doing their job and the devastating impact that's going to have on our nation. And
1:15.4	today's guest is Ian Tanak, who should need no introduction, a legend of the laboratory,
1:20.9	of dosataxil, of prostate cancer, and of clinical trial appraisal. You won't want to miss
1:25.8	his thoughts on a career in medicine. So, stay tuned.
1:35.4	First up, this is our annual pledge drive.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.